对Cdx2 VDR基因多态性 rs11568820与斯洛伐克人的多发性硬化症相关的分析
Daniel Čierny1, Dušan Dobrota1, Ema Kantorová2
1Department of Clinical Biochemistry, Jessenius Faculty of Medicine, Comenius University in Bratislava and University Hospital Martin, Martin, Slovak Republic.
Neurological research
|August 15, 2023
概括
这项研究发现Cdx-2基因变异与斯洛伐克人口多发性硬化症 (MS) 风险或进展之间没有关联. 然而,HLA-DRB1*15:01等位基因显著增加了MS风险.
科学领域:
- 神经免疫学 神经免疫学
- 遗传学 是一个遗传学.
- 自免疫性疾病 自免疫性疾病
背景情况:
- 维生素D缺乏与多发性硬化症 (MS) 病变发生有关.
- Cdx-2基因多态 (rs11568820) 影响维生素D受体 (VDR) 转录活性,可能影响MS风险.
- HLA-DRB1*15:01等位基因是MS的已知风险因素.
研究的目的:
- 调查Cdx-2基因变异与斯洛伐克人口中MS风险和残疾进展的关联.
- 评估HLA-DRB1*15:01等位基因对这种关联的潜在混作用.
主要方法:
- 在493名多发性硬化患者和417名对照患者中,对Cdx-2变异和HLA-DRB1*15:01代用标记物 (rs3135388) 的基因定型.
- 使用后勤回归分析等位基因和基因型关联的分析.
- 使用多发性硬化症严重程度评分评估疾病残疾进展.
主要成果:
- 在Cdx-2变体和MS风险 (OR=1.15,p=0.289) 之间没有发现显著的等位基相关性.
- 后勤回归模型 (附加性,主导性,衰退性) 显示Cdx-2基因型与MS风险之间没有关联 (p > 0.150).
- Cdx-2变异与MS残疾进展无关.
- 这种HLA-DRB1*15:01等位基因极大地增加了MS风险 (主要模型OR=4.62,p=9.1×10−23).
结论:
- 在斯洛伐克人口中,Cdx-2基因多态性不是MS发展或进展的显著遗传风险因素.
- 证实了HLA-DRB1*15:01与MS风险的强烈关联.
- 该研究没有发现Cdx-2在这个队列中是MS的独立遗传标志物.
关键词:
Cdx-2 (rs11568820) 的时间在HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中,HLA-DRB1*15:01中多发性硬化症是多发性硬化症.障碍的进展,残疾的进展.基因多形态的多态化易感性 易感性 易感性维生素D受体是维生素D的受体.更多相关视频
相关概念视频
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Incomplete Dominance
22.8K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
22.8K


